Abstract |
Midpotency topical corticosteroids (TCSs) are frequently used for the treatment of common eczematous and inflammatory skin disorders in both adults and children. There are several commercially available products in this category, and many vehicles and formulations for the clinician to choose from. Clocortolone pivalate 0.1% cream is a midpotency TCS formulated in an emollient formulation that has been shown to be effective and well tolerated when used appropriately in the management of several corticosteroid-responsive dermatoses. This article discusses the physiochemical properties of the compound; the characteristics of its emollient cream formulation; the functions of individual excipients; and the efficacy, tolerability, and safety data supporting its use in adults and children, including for facial involvement.
|
Authors | James Q Del Rosso, Leon H Kircik |
Journal | Journal of drugs in dermatology : JDD
(J Drugs Dermatol)
Vol. 12
Issue 2
Pg. s5-s10
(Feb 2013)
ISSN: 1545-9616 [Print] United States |
PMID | 23377405
(Publication Type: Journal Article)
|
Chemical References |
- Glucocorticoids
- Ointments
- Fluocortolone
- clocortolone pivalate
|
Topics |
- Administration, Topical
- Adult
- Chemistry, Pharmaceutical
- Child
- Dermatitis, Contact
(drug therapy, pathology)
- Eczema
(drug therapy, pathology)
- Face
- Fluocortolone
(administration & dosage, adverse effects, analogs & derivatives, therapeutic use)
- Glucocorticoids
(administration & dosage, adverse effects, therapeutic use)
- Humans
- Ointments
- Psoriasis
(drug therapy, pathology)
- Skin
(pathology)
- Skin Diseases
(drug therapy, pathology)
|